Wolverine 10mg is a co-formulated research reference compound pairing two widely studied peptides, BPC-157 (5 mg) and TB-500 (5 mg), in a single lyophilized vial. The pairing gives investigators a fixed, reproducible starting point for examining how a body-protective compound and a synthetic seven-residue fragment of thymosin beta-4 behave together in cell-culture and preclinical models of tissue maintenance and repair.

As a reference material, BPC-157 is frequently studied for its association with angiogenic and cytoprotective signaling, while TB-500 is investigated for G-actin binding and cell migration. Combining both in a defined 5 mg + 5 mg ratio lets researchers explore potential additive or synergistic interactions between the two mechanisms within a controlled in-vitro system, without reformulating from separate stocks.

Key research areas

  • Synergistic and additive tissue-repair models combining angiogenic and actin-regulating pathways
  • Tendon, ligament, and skeletal-muscle injury paradigms in preclinical and cell-culture settings
  • Cell migration, proliferation, and cytoprotection assays
  • Anti-inflammatory and vascular-response signaling investigations
  • Comparative studies of combined versus single-peptide exposure

Specifications

  • Contents: BPC-157 5 mg + TB-500 5 mg (10 mg total per vial)
  • Form: Lyophilized white powder
  • Storage: Refrigerate at 2–8°C; keep lyophilized until reconstitution
  • Testing: Third-party tested for identity and purity; a Certificate of Analysis is available on request
  • Sourcing: Supplied by Echo Peptides from qualified production channels

This product is offered for in-vitro laboratory research use only and is not intended for human or veterinary use, nor for any diagnostic or therapeutic purpose.